Pictet Asset Management (UK)’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
AC
SCM
Pictet Asset Management (UK)'s BLUE Position: Q2 2021 in Review
Pictet Asset Management (UK) increased its bluebird bio (BLUE) stake by 145% in Q2 2021, buying an estimated $3.39M and bringing the position to 14,464 shares worth $5.99M. The position accounts for 0.01% of the portfolio, ranked #805.
Pictet Asset Management (UK) first reported a position in BLUE in Q4 2015 and has held it in 20 quarters since. The position peaked at $29.3M in Q4 2017. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.
- Pictet Asset Management (UK) held 14,464 shares of bluebird bio worth $5.99M as of Q2 2021.
- Pictet Asset Management (UK) bought 8,566 bluebird bio shares in Q2 2021, an estimated $3.39M.
- bluebird bio made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #805 holding.
- Pictet Asset Management (UK) first reported a position in bluebird bio in Q4 2015 and has held it in 20 quarters since.
- Pictet Asset Management (UK)'s bluebird bio position peaked at $29.3M in Q4 2017.
- 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.